BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 22420613)

  • 1. Significance of PC cell-derived growth factor and cyclin D1 expression in cutaneous squamous cell carcinoma.
    Huang K; Huang C; Shan K; Chen J; Li H
    Clin Exp Dermatol; 2012 Jun; 37(4):411-7. PubMed ID: 22420613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of PC cell-derived growth factor and vascular endothelial growth factor in esophageal squamous cell carcinoma and their clinicopathologic significance.
    Chen XY; Li JS; Liang QP; He DZ; Zhao J
    Chin Med J (Engl); 2008 May; 121(10):881-6. PubMed ID: 18706200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
    Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S
    Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of phosphorylated-STAT3 correlated with the invasion and metastasis of cutaneous squamous cell carcinoma.
    Suiqing C; Min Z; Lirong C
    J Dermatol; 2005 May; 32(5):354-60. PubMed ID: 16043897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An overview of Bcl-2 expression in histopathological variants of basal cell carcinoma, squamous cell carcinoma, actinic keratosis and seborrheic keratosis.
    Puizina-Ivić N; Sapunar D; Marasović D; Mirić L
    Coll Antropol; 2008 Oct; 32 Suppl 2():61-5. PubMed ID: 19138009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression of SnoN in normal human skin and cutaneous keratinous neoplasms.
    Zhang X; Egawa K; Xie Y; Ihn H
    Int J Dermatol; 2009 Jun; 48(6):579-83. PubMed ID: 19538364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of ezrin in epithelial skin tumors: cytoplasmic ezrin immunoreactivity in squamous cell carcinoma.
    Park HR; Min SK; Min K; Jun SY; Seo J; Kim KH; Choi J
    Int J Dermatol; 2010 Jan; 49(1):48-52. PubMed ID: 20465611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of Oct-4 transcription factor in squamous cell skin carcinoma and seborrheic keratosis].
    Li YY; Dai YJ; Deng B; Liang XA; Xie ZJ; Chen HF
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 May; 31(5):917-8. PubMed ID: 21602158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heat shock protein 105 is overexpressed in squamous cell carcinoma and extramammary Paget disease but not in basal cell carcinoma.
    Muchemwa FC; Nakatsura T; Ihn H; Kageshita T
    Br J Dermatol; 2006 Sep; 155(3):582-5. PubMed ID: 16911285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of RPE65, a putative receptor for plasma retinol-binding protein, in nonmelanocytic skin tumours.
    Hinterhuber G; Cauza K; Dingelmaier-Hovorka R; Diem E; Horvat R; Wolff K; Foedinger D
    Br J Dermatol; 2005 Oct; 153(4):785-9. PubMed ID: 16181461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of CD10 and Bcl2 expression in distinguishing cutaneous basal cell carcinoma from squamous cell carcinoma and seborrheic keratosis.
    Gaballah MA; Ahmed RA
    Pathol Res Pract; 2015 Dec; 211(12):931-8. PubMed ID: 26573127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of STAT3 and MAPK phosphorylation, and the protein expression of cyclin D1 in skin squamous cell carcinoma tissues.
    Wu J; Lu WY; Cui LL
    Mol Med Rep; 2015 Dec; 12(6):8129-34. PubMed ID: 26497194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of cyclin D1 in nonmelanocytic skin cancer.
    Liang SB; Furihata M; Takeuchi T; Iwata J; Chen BK; Sonobe H; Ohtsuki Y
    Virchows Arch; 2000 Apr; 436(4):370-6. PubMed ID: 10834541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical expression of ezrin in cutaneous basal and squamous cell carcinomas.
    Abdou AG; Maraee AH; El-Sayed EM; Elnaidany NF
    Ann Diagn Pathol; 2011 Dec; 15(6):394-401. PubMed ID: 21849257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of RUNX3 in skin cancers.
    Lee JH; Pyon JK; Kim DW; Lee SH; Nam HS; Kang SG; Kim CH; Lee YJ; Chun JS; Cho MK
    Clin Exp Dermatol; 2011 Oct; 36(7):769-74. PubMed ID: 21623876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteinase-activated receptor-2 expression in basal and squamous cell carcinomas compared with normal skin.
    Dastgheib L; Monabati A; Mohammadian A; Sari-Aslani F; Marzban S; Namazi MR
    J Cutan Pathol; 2009 Mar; 36(3):314-7. PubMed ID: 19032384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCR10 and CCL27 are overexpressed in cutaneous squamous cell carcinoma.
    Kai H; Kadono T; Kakinuma T; Tomita M; Ohmatsu H; Asano Y; Tada Y; Sugaya M; Sato S
    Pathol Res Pract; 2011 Jan; 207(1):43-8. PubMed ID: 21144674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of PC cell-derived growth factor (PCDGF)/granulin-epithelin precursor (GEP) decreased cell proliferation and invasion through downregulation of cyclin D and CDK4 and inactivation of MMP-2.
    Liu Y; Xi L; Liao G; Wang W; Tian X; Wang B; Chen G; Han Z; Wu M; Wang S; Zhou J; Xu G; Lu Y; Ma D
    BMC Cancer; 2007 Jan; 7():22. PubMed ID: 17261172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of two androgen-induced proteins (pepsinogen C and apolipoprotein d) in epithelial skin cancers of the eyelids.
    Alvarez ML; Barbón JJ; González LO; Lamelas ML; Vázquez J; Vizoso FJ
    Ophthalmologica; 2004; 218(2):115-9. PubMed ID: 15004501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Greater expression of TC21/R-ras2 in highly aggressive malignant skin cancer.
    Lee JH; Pyon JK; Lee SH; Lee YJ; Kang SG; Kim CH; Kim DW; Nam HS; Park YH; Jeong DJ; Cho MK
    Int J Dermatol; 2011 Aug; 50(8):956-60. PubMed ID: 21781067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.